Operator of a biotechnology company intended to invent novel treatment options for autoimmune diseases and cancer. The company offers an immunomodulatory antibody drug, an antibody-based-immune modulating biologics that utilizes antibodies to modulate the immune system through innovative mechanisms of action, enabling clients to come up with new ways to treat cancer using modern biotechnological techniques.